Protective cell-mediated immunity against Cryptococcus neoformans

Research in Immunology

Volumn 149, Issue 4-5, 1998, Pages 373-386

  Murphy, J W ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN EXPRESSION; CELL SURVIVAL; CELLULAR IMMUNITY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE PREDISPOSITION; HELPER CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MENINGOENCEPHALITIS; PRIORITY JOURNAL; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE;

EID: 0032077837     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80761-X     Document Type: Article

References (94)

1. Abrahams, I. (1966), Further studies on acquired resistance to murine cryptococcosis: enhancing effect of Bordetella pertussis. J. Immun., 96, 525-529.
2. Aguirre, K., Havell, E.A., Gibson, G.W. & Johnson, L.L. (1995), Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun., 63, 1725-1731.
3. Aguirre, K.M. & Johnson, L.L. (1997), A role for B cells in resistance to Cryptococcus neoformans in mice. Infect. Immun., 65, 525-530.
4. Aguirre, K.M., Sayles, P.C., Gibson, G.W. & Johnson, L.L. (1996), Resistance to Cryptococcus neoformans is associated with an inflammatory response to Toxoplasma gondii in the central nervous system of mice. Infect. Immun., 64, 77-82.
5. Anderson, D.M. & Dykstra, M.A. (1984), Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans. Mycopathologia, 86, 169-177.
6. Bour, H., Peyron, E., Gaucherand, M., Garrigue, J.-L., Desvignes, C., Kaiserlian, D., Revillard, J.-P. & Nicolas, J.-F. (1995), Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur. J. Immunol., 25, 3006-3010.
7. Buchanan, K.L., Fidel, P.L. & Murphy, J.W. (1991), Effects of Cryptococcus neoformans-specific suppressor T cells on the amplified anticryptococcal delayed-type hypersensitivity response. Infect. Immun., 59, 29-35.
8. Buchanan, K.L. & Murphy, J.W. (1993), Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect. Immun., 61, 2854-2865.
9. Buchanan, K.L. & Murphy, J.W. (1994), Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect. Immun., 62, 2930-2939.
10. Buchanan, K.L. & Murphy, J.W. (1997), Kinetics of cellular infiltration and cytokine production during the efferent phase of a delayed-type hypersensitivity reaction. Immunology, 90, 189-197.
11. Cauley, L. K. & Murphy, J.W. (1979), Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect. Immun., 23, 644-651.
12. Chu, R.S., Targoni, O.S., Krieg, A.M., Lehmann, P.V. & Harding, C.V. (1997), CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med., 186, 1623-1631.
13. Clemons, K.V., Brummer, E. & Stevens, D.A. (1994), Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother., 38, 460-464.
14. Crowle, A.J. (1975), Delayed hypersensitivity in the mouse. Adv. Immunol., 20, 197-264.
15. Delfino, D., Cianci, L., Lupis, E., Celeste, A., Petrelli, M.L., Curro, F., Cusumano, V. & Teti, G. (1997), Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. Infect. Immun., 65, 2454-2456.
16. Delfino, D., Cianci, L., Migliardo, M., Mancuso, G., Cusumano, V., Corradini, C. & Teti, G. (1996), Tumor necrosis factor-inducing activities of Cryptococcus neoformans components. Infect. Immun., 64, 5199-5204.
17. Domer, J.E., Lyon, F.L. & Murphy, J.W. (1983), Cellular immunity in a cutaneous model of cryptococcosis. Infect. Immun., 40, 1052-1059.
18. Dong, Z.M. & Murphy, J.W. (1995), Effects of two varieties of Cryptococcus neoformans cells and culture filtrate antigens on neutrophil locomotion. Infect. Immun., 63, 2632-2644.
19. Doyle, H.A. & Murphy, J.W. (1997), MIP-1α contributes to the anticryptococcal delayed-type hypersenshivity reaction and protection against Cryptococcus neoformans. J. Leukoc. Biol., 61, 147-155.
20. Dykstra, M.A. & Friedman, L. (1978), Pathogenesis, lethality, and immunizing effect of experimental cutaneous cryptococcosis. Infect. Immun., 20, 446-455.
21. Fidel, P.L. & Murphy, J.W. (1989), Effects of cyclosporin on the cells responsible for the anticryptococcal cell-mediated immune response and its regulation. Infect. Immun., 57, 1158-1164.
22. Fidel, P.L. & Murphy, J.W. (1990), Characterization of a cell population which amplifies the anticryptococcal delayed-type hypersensitivity response. Infect. Immun., 58, 393-398.
23. Flesch, I.E., Schwamberger, G. & Kaufmann, S.E. (1989), Fungicidal activity of IFN-γ-activated macrophages. Extracellular killing of Cryptococcus neoformans. J. Immunol., 142, 3219-3224.
24. Fung, P.Y. & Murphy, J.W. (1982), In vitro interactions of immune lymphocytes and Cryptococcus neoformans. Infect. Immun., 36, 1128-1138.
25. Gadebusch, H.H. (1958), Active immunization against Cryptococcus neoformans. J. Infect. Dis., 102, 219-226.
26. Gentry, L.O. & Remington, J.S. (1971), Resistance against Cryptococcus conferred by intracellular bacteria and protozoa. J. Infect. Dis., 123, 22-31.
27. Goust, J.-M. & Bierer, B. (1993), Cell-mediated immunity. Immunology Series, 58, 187-212.
28. Graybill, J.R. & Drutz, D.J. (1978), Host defense in cryptococcosis in the nude mouse. Cell. Immunol., 40, 263-274.
29. Graybill, J.R., Mitchell, L. & Drutz, D.J. (1979), Host defense in cryptococcosis. III. Protection of nude mice by thymus transplantation. J. Infect. Dis., 140, 546-552.
30. Graybill, J.R. & Taylor, R.L. (1978), Host defense in cryptococcosis. I. An in vivo model for evaluating immune responses. Int. Archs. Allergy Appl. Immun., 57, 101-108.
31. + T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med., 175, 1685-1695.
32. Hill, J.O. & Aguirre, K.M. (1994), CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans. J. Immunol., 152, 2344-2350.
33. + T-cells. J. Exp. Med., 173, 755-758.
34. Hoag, K.A., Street, N.E., Huffnagle, G.B. & Lipscomb, M.F. (1995), Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am J. Respir. Cell Mol. Biol., 13, 487-495.
35. Hoag, K.A., Lipscomb, M.F., Izzo, A.A. & Street, N.B. (1997), IL-12 and IFN-γ are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol., 17, 733-739.
36. + T cells through IL-12 produced by Listeria-induced macrophages. Science, 260, 547-549.
37. Huffnagle, G.B., Lipscomb, M.F., Lovchik, J.A., Hoag, K.A. & Street, N.B. (1994), The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukoc. Biol., 55, 35-42.
38. Huffnagle, G.B., Stricter, R.M., McNeil, L.K., McDonald, R.A., Burdick, M.D., Kunkel, S.L. & Toews, G.B. (1997), Macrophage inflammatory protein-1α (MIP-1α) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol., 159, 318-327.
39. Huffnagle, G.B., Strieter, R.M., Standiford, T.J., McDonald, R.A., Burdick, M.D., Kunkel, S.L. & Toews, G.B. (1995), The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol., 155, 4790-4797.
40. Huffnagle, G.B., Toews, G.B., Burdick, M.D., Boyd, M.B., McAllister, K.S., McDonald, R.A., Kunkel, S.L. & Strieter, R.M. (1996), Afferent phase production of TNF-α required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol., 157, 4529-4536.
41. + T cells. J. Exp. Med., 173, 793-800.
42. Huffnagle, G.B., Yates, J.L. & Lipscomb, M.F. (1991b), T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun., 59, 1423-1433.
43. Ingulli, E., Mondino, A., Khoruts, A. & Jenkins, M.K. (1997), In vivo detection of dendritic cell antigen presentation to CD4+ T cells. J. Exp. Med., 12, 2133-2141.
44. Janeway, C.A. & Travers, P. (1996), "Immunobiology. The Immune System in Health and Disease" second ed., Garland Publishing Inc., New York.
45. Kawakami, K., Kohno, S., Kadota, J.I., Tohyama, M., Teruya, K., Kudeken, N., Saito, A. & Hara, K. (1995), T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: involvement of IFN-γ and its protective effect against cryptococcal infection. Microbiol Immunol., 39, 135-143.
46. Kawakami, K., Qureshi, M.H., Zhang, T., Okamura, H., Kurimoto, M. & Saito, A. (1997b), IL-18 products mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ production. J. Immunol., 159, 5528-5534.
47. Kawakami, K., Tohyama, M., Qifeng, X. & Saito, A. (1997), Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun., 45, 1309-1312.
48. Kawakami, K., Tohyama, M., Teruya, K., Kudeken, N., Xie, Q. & Saito, A. (1996a), Contribution of interferon-γ in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans. FEMS Immunol. Med. Microbiol., 13, 123-130.
49. Kawakami, K., Tohyama, M., Xie, Q. & Saito, A. (1996b), Interleukin-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol., 104, 208-214.
50. Khakpour, F.R. & Murphy, J.W. (1987), Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s). Infect. Immun., 55, 1657-1662.
51. Kwon-Chung, K.J. & Bennett, J.E. (1992), In "Medical Mycology" (K.J. Kwon-Chung and J.E. Bennett, eds.), pp. 397-446. Lea & Febiger, Philadelphia.
52. Levitz, S.M., Tabuni, A., Kornfeld, H., Reardon, C.C. & Golenbock, D.T. (1994), Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun., 62, 1975-1981.
53. Lim, T.S. & Murphy, J.W. (1980), Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice. Infect. Immun., 30, 5-11.
54. Lim, T.S., Murphy, J.W. & Cauley, L.K. (1980), Hostetiological agent interactions in intranasally and intraperitoneally induced cryptococcosis in mice. Infect. Immun., 29, 633-641.
55. Lipscomb, M.F., Huffnagle, G.B., Lovchik, J.A., Lyons, C.R., Pollard, A.M. & Yates, J.L. (1993), The role of T lymphocytes in pulmonary microbial defense mechanisms. Arch. Pathol. Lab. Med., 117, 1225-1232.
56. Louria, D. B. (1960), Specific and non-specific immunity in experimental cryptococcosis in mice. J. Exp. Med., 111, 643-665.
57. Louria, D.B., Kaminski, T. & Finkel, G. (1963), Further studies on immunity in experimental cryptococcosis. J. Exp. Med., 117, 509-520.
58. Mackaness, G.B. (1971), Cellular resistance to infection. J. Exp. Med., 116, 381-406.
59. Mitchell, T.G. & Perfect, J.R. (1995), Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin. Microbiolo. Rev., 8, 515-548.
60. Mody, C.H., Chen, G., Jackson, C., Curtis, J.L. & Toews, G.B. (1993a), Depletion of mutine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Crytpcoccus neoformans. J. Lab. Clin. Med., 121, 765-773.
61. Mody, C.H., Chen, G.H., Jackson, C., Curtis, J.L. & Toews, G.B. (1993b), In vivo depletion of murine CD8 positive T cells impairs survival during infection with a highly virulent strain of Cryptococcus neoformans. Mycopathologia, 125, 7-17.
62. +) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J. Immunol., 144, 1472-1477.
63. Mody, C.H., Paine, R., III, Jackson, C., Chen, G.H. & Toews, G.B. (1994), CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans. J. Immunol., 152, 3970-3979.
64. Mody, C.H., Tyler, C.L., Sitrin, R.G., Jackson, C. & Toews, G.B. (1991), Interferon-γ activates rat alveolar macrophages for anticryptococcal activity. Am. J. Resp. Cell Mol. Biol., 5, 19-26.
65. Moser, S.A., Lyon, F.L., Domer, J.E. & Williams, J.E. (1982), Immunization of mice by intracutaneous inoculation with viable virulent Cryptococcus neoformans: immunological and histopathological parameters. Infect. Immun., 35, 685-696.
66. Murphy, J.W. (1989a), Clearance of Cryptococcus neoformans from immunologically suppressed mice. Infect. Immun., 57, 1946-1952.
67. Murphy, J.W. (1989b), In "Immunology of fungal diseases" (E. Kurstak, ed.), pp. 319-345. Marcel Dekker, New York.
68. Murphy, J.W. (1993), Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect. Immun., 61, 4750-4759.
69. Murphy, J.W. (1996), In "The Mycota VI Human and Animal Relationships" (D.H. Howard and J.D. Miller, eds.), pp. 67-97. Springer-Verlag, Berlin.
70. Murphy, J.W., Gregory, J.A. & Larsh, H.W. (1974), Skin testing of guinea pigs and footpad testing of mice with a new antigen for detecting delayed hypersensitivity to Cryptococcus neoformans. Infect. Immun., 9, 404-409.
71. Murphy, J.W. & Moorhead, J.W. (1982), Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen. J. Immunol., 128, 276-283.
72. Murphy, J.W. & Mosley, R.L. (1985), Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2). J. Immunol., 134, 577-584.
73. Murphy, J.W. & Pahlavan, N. (1979), Cryptococcal culture filtrate antigen for detection of delayed-type hypersensitivity in cryptococcosis. Infect. Immun., 25, 284-292.
74. Murphy, J.W., Schafer, F., Casadevall, A. & Adesina, A. (1998), Antigen-induced protective and non-protective cell-mediated immune components against Cryptococcus neoformans. Infect. Immunol., 66, 2632-2634.
75. Muth, S.M. & Murphy, J.W. (1995a), Direct anticryptococcal activity of lymphocytes from Cryptococcus neoformans-immunized mice. Infect. Immun., 63, 1637-1644.
76. Muth, S.M. & Murphy, J.W. (1995b), Effects of immunization with Cryptococcus neoformans cells or cryptococcal culture filtrate antigen on the direct anticryptococcal activities of murine T lymphocytes. Infect. Immun., 63, 1645-1651.
77. Nishimura, K. & Miyaji, M. (1979), Histopathological studies on experimental cryptococcosis in nude mice. Mycopathology, 68, 145-153.
78. Pereira, H.A., Shafer, W.M., Pohl, J., Martin, L.E. & Spitznagel, J.K. (1990), CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J. Clin. Invest., 85, 1468-1476.
79. Perez, V.L., Parijs, L.V., Biuckians, A., Zheng, X.X., Strom, T.B. & Abas, A.K. (1997), Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity, 6, 411-417.
80. Powderly, W.G. (1992), Therapy for cryptococcal meningitis in patients with AIDS. Clin. Infect. Dis., 14, S54-S59.
81. Retini, C., Vecchiarelli, A., Monari, C., Tascini, C., Bistoni, F. & Kozel, T.R. (1996), Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect. Immun., 64, 2897-2903.
82. Rollins, B.J. (1997), Chemokines. Blood, 90, 909-928.
83. Salkowski, C. & Balish, E. (1991a), A monoclonal antibody to gamma interferon blocks augmentation of natural killer cell activity induced during systemic cryptococcosis. Infect. Immun., 59, 486-493.
84. Salkowski, C.A. & Balish, E. (1991b), Cutaneous cryptococcosis in athymic and beige-athymic mice. Infect. Immun., 59, 1785-1789.
85. Spitzer, E.D., Spitzer, S.G., Freundlich, L.F. & Casadevall, A. (1993), Persistence of the initial infection in recurrent cryptococcal meningitis. Lancet, 341, 505-596.
86. Standiford, T.J., Rolfe, M.W., Kunkel, S.L., Lynch, J.P., Burdick, M.D., Gilbert, A.R., Orringer, M.B., Whyte, R.J. & Strieter, R.M. (1993), Macrophage inflammatory protein-1α expression in interstitial lung disease. J. Immunol., 151, 2852-2863.
87. Unanue, E.R. (1997), Macrophages, NK cells and neutrophils in the cytokine loop of Listeria resistance. Res. Immunol., 147, 499-505.
88. Ushio, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Akita, K., Tanabe, F., Konishi, K., Micallef, M., Fujii, M., Torigoe, K., Tanimoto, T., Fukuda, S., Ikeda, M., Okamura, H. & Kurimoto, M. (1996), Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol., 156, 4274-4279.
89. Vecchiarelli, A., Dottorini, M., Pietrella, D., Monari, C., Retini, C., Todisco, T. & Bistoni, F. (1994), Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol., 11, 130-137.
90. Vecchiarelli, A., Retini, C., Pietrella, D., Monari, C., Tascini, C., Beccari, T. & Kozel, T.R. (1995), Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1β secretion from human monocytes. Infect. Immun., 63, 2919-2923.
91. Wilson, S.D., Burd, P.R., Billings, P.R., Martin, C.A. & Dorf, M.E. (1988), The expression and regulation of a potential lymphokine gene (TCA3) in CD4 and CD8 T cell clones. J. Immunol., 141, 1563-1570.
92. Xu, H., Dilulio, N.A. & Fairchild, R.L. (1996), T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: IFNγ producing (Tc1) effector CD8+ T cells and IL-4/IL-10 producing (Th2) negative regulatory CD4+ T cells. J. Exp. Med., 183, 1001-1012.
93. Xu-Amano, J., Jackson, R.J., Fujihashi, H., Kiyono, H., Staats, H.F. & McGhee, J.R. (1994), Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine, 12, 903-911.
94. Yuan, R.R., Casadevall, A., Oh, J. & Scharff, M.D. (1997), T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. Proc. Natl. Acad. Sci. USA, 94, 2483-2488.